Merck (MRK) call put ratio 1 call to 5.9 puts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil falls on weaker demand outlook and higher US stocks
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
CFRA Upgrades Merck (MRK) to Buy (midday)
November 19, 2024 4:27 PM ESTCFRA upgraded Merck (NYSE: MRK) from Hold to Buy with a price target of $108.00.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $96.56 yesterday.
... MoreJPMorgan Reiterates Overweight Rating on Merck (MRK)
November 19, 2024 8:44 AM ESTJPMorgan analyst Chris Schott reiterated an Overweight rating and $145.00 price target on Merck (NYSE: MRK).
The analyst comments "This morning, MRK announced that the Ph3 trial for the subQ formulation of Keytruda (with berahyaluronidase alfa) met its dual primary PK endpoints, which we see as removing tail risk to the story as we think about the longer-term... More
